Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Convergent synthesis of hydrophilic monomethyl dolastatin 10 based drug linkers for antibody-drug conjugation.

Yang K, Chen B, Gianolio DA, Stefano JE, Busch M, Manning C, Alving K, Gregory RC, Brondyk WH, Miller RJ, Dhal PK.

Org Biomol Chem. 2019 Sep 21;17(35):8115-8124. doi: 10.1039/c9ob01639b. Epub 2019 Aug 28.

PMID:
31460552
2.

Supramolecular Assembly of Human Pulmonary Surfactant Protein SP-D.

Arroyo R, Martín-González A, Echaide M, Jain A, Brondyk WH, Rosenbaum J, Moreno-Herrero F, Pérez-Gil J.

J Mol Biol. 2018 May 11;430(10):1495-1509. doi: 10.1016/j.jmb.2018.03.027. Epub 2018 Apr 4.

PMID:
29626540
3.

Design, Synthesis, and in vitro Evaluation of Multivalent Drug Linkers for High-Drug-Load Antibody-Drug Conjugates.

Chen B, Gianolio DA, Stefano JE, Manning CM, Gregory RC, Busch MM, Brondyk WH, Miller RJ, Dhal PK.

ChemMedChem. 2018 Apr 23;13(8):790-794. doi: 10.1002/cmdc.201700722. Epub 2018 Mar 8.

PMID:
29517131
4.

Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.

Turner MJ, Pang PT, Chretien N, Havari E, LaMorte MJ, Oliver J, Pande N, Masterjohn E, Carter K, Reczek D, Brondyk W, Roberts BL, Kaplan JM, Siders WM.

J Neuroimmunol. 2015 Aug 15;285:4-12. doi: 10.1016/j.jneuroim.2015.05.018. Epub 2015 May 20.

5.

Capture-stabilize approach for membrane protein SPR assays.

Chu R, Reczek D, Brondyk W.

Sci Rep. 2014 Dec 8;4:7360. doi: 10.1038/srep07360.

6.

Site-specific antibody-drug conjugation through glycoengineering.

Zhou Q, Stefano JE, Manning C, Kyazike J, Chen B, Gianolio DA, Park A, Busch M, Bird J, Zheng X, Simonds-Mannes H, Kim J, Gregory RC, Miller RJ, Brondyk WH, Dhal PK, Pan CQ.

Bioconjug Chem. 2014 Mar 19;25(3):510-20. doi: 10.1021/bc400505q. Epub 2014 Feb 28.

PMID:
24533768
7.

Human choriocarcinomas: placental growth factor-dependent preclinical tumor models.

Bagley RG, Ren Y, Kurtzberg L, Weber W, Bangari D, Brondyk W, Teicher BA.

Int J Oncol. 2012 Feb;40(2):479-86. doi: 10.3892/ijo.2011.1257. Epub 2011 Nov 10.

PMID:
22075622
8.

Biotherapeutic target or sink: analysis of the macrophage mannose receptor tissue distribution in murine models of lysosomal storage diseases.

Zhang XS, Brondyk W, Lydon JT, Thurberg BL, Piepenhagen PA.

J Inherit Metab Dis. 2011 Jun;34(3):795-809. doi: 10.1007/s10545-011-9285-9. Epub 2011 Mar 17.

PMID:
21416197
9.

Placental growth factor upregulation is a host response to antiangiogenic therapy.

Bagley RG, Ren Y, Weber W, Yao M, Kurtzberg L, Pinckney J, Bangari D, Nguyen C, Brondyk W, Kaplan J, Teicher BA.

Clin Cancer Res. 2011 Mar 1;17(5):976-88. doi: 10.1158/1078-0432.CCR-10-2687. Epub 2011 Feb 22.

10.

Selecting an appropriate method for expressing a recombinant protein.

Brondyk WH.

Methods Enzymol. 2009;463:131-47. doi: 10.1016/S0076-6879(09)63011-1. Review.

PMID:
19892171
11.

LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.

Reczek D, Schwake M, Schröder J, Hughes H, Blanz J, Jin X, Brondyk W, Van Patten S, Edmunds T, Saftig P.

Cell. 2007 Nov 16;131(4):770-83.

12.

Surfactant protein-D and surfactant inhibit endotoxin-induced pulmonary inflammation.

Ikegami M, Scoville EA, Grant S, Korfhagen T, Brondyk W, Scheule RK, Whitsett JA.

Chest. 2007 Nov;132(5):1447-54. Epub 2007 Oct 9.

PMID:
17925426
13.

Intratracheal recombinant surfactant protein d prevents endotoxin shock in the newborn preterm lamb.

Ikegami M, Carter K, Bishop K, Yadav A, Masterjohn E, Brondyk W, Scheule RK, Whitsett JA.

Am J Respir Crit Care Med. 2006 Jun 15;173(12):1342-7. Epub 2006 Mar 23.

14.

Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function.

Rouleau C, Roy A, St Martin T, Dufault MR, Boutin P, Liu D, Zhang M, Puorro-Radzwill K, Rulli L, Reczek D, Bagley R, Byrne A, Weber W, Roberts B, Klinger K, Brondyk W, Nacht M, Madden S, Burrier R, Shankara S, Teicher BA.

Mol Cancer Ther. 2006 Feb;5(2):219-29.

15.

Structure-expression relationship of tumor necrosis factor receptor mutants that increase expression.

Schweickhardt RL, Jiang X, Garone LM, Brondyk WH.

J Biol Chem. 2003 Aug 1;278(31):28961-7. Epub 2003 Apr 26.

16.

The GTPase Rab3a is associated with large dense core vesicles in bovine chromaffin cells and rat PC12 cells.

Darchen F, Senyshyn J, Brondyk WH, Taatjes DJ, Holz RW, Henry JP, Denizot JP, Macara IG.

J Cell Sci. 1995 Apr;108 ( Pt 4):1639-49.

17.

Interaction cloning of Rabin3, a novel protein that associates with the Ras-like GTPase Rab3A.

Brondyk WH, McKiernan CJ, Fortner KA, Stabila P, Holz RW, Macara IG.

Mol Cell Biol. 1995 Mar;15(3):1137-43.

18.

Use of two-hybrid system to identify Rab binding proteins.

Brondyk WH, Macara IG.

Methods Enzymol. 1995;257:200-8. No abstract available.

PMID:
8583922
19.

Oligonucleotide mutagenesis of Rab GTPases.

Macara IG, Brondyk WH.

Methods Enzymol. 1995;257:107-18. No abstract available.

PMID:
8583912
20.

Evidence for the involvement of Rab3A in Ca(2+)-dependent exocytosis from adrenal chromaffin cells.

Holz RW, Brondyk WH, Senter RA, Kuizon L, Macara IG.

J Biol Chem. 1994 Apr 8;269(14):10229-34.

22.

Regulation of the GTPase cycle of the neuronally expressed Ras-like GTP-binding protein Rab3A.

Burstein ES, Brondyk WH, Macara IG, Kaibuchi K, Takai Y.

J Biol Chem. 1993 Oct 25;268(30):22247-50.

23.
24.
25.
26.
27.

Fibronectin levels are enhanced in human fibroblasts overexpressing the c-sis protooncogene.

Allen-Hoffmann BL, Schlosser SJ, Brondyk WH, Fahl WE.

J Biol Chem. 1990 Mar 25;265(9):5219-25.

28.

Supplemental Content

Loading ...
Support Center